The Silent Strokes: Cerebral Microbleeds: Pathophysiology to Clinical Practice
With the advent of highly sensitive MRI sequences (like T2* and Susceptibility-Weighted Imaging), neurologists began noticing tiny, dark voids scattered throughout the brains of aging patients. These are cerebral microbleeds—microscopic hemorrhages that were invisible on traditional CT scans. Once considered benign incidental findings, they are now recognized as powerful harbingers of cognitive decline and catastrophic macro-hemorrhages. Cerebral Microbleeds: Pathophysiology to Clinical Practice is the definitive, fiercely clinical text dedicated to this emerging neurovascular threat. This volume provides the exact blueprints required by neurologists to interpret these lesions and make agonizing decisions regarding anticoagulation therapy.
Mastering the Topography of Microvascular Disease
The core philosophy of this text is anatomical correlation. The authors aggressively detail the distinct etiologies behind microbleeds based on their specific location in the brain. It dictates exactly how to differentiate between deep/infratentorial microbleeds (the hallmark of hypertensive small vessel disease) and strictly lobar microbleeds (the classic signature of cerebral amyloid angiopathy). It provides the crucial framework for diagnosing CAA before a fatal lobar hemorrhage occurs.
Navigating the Anticoagulation Dilemma
The book provides a masterclass in clinical risk assessment. It dictates the exact clinical pathways for managing patients who desperately need blood thinners (e.g., for atrial fibrillation) but who harbor numerous cerebral microbleeds. It provides exhaustive reviews of the current literature, helping clinicians weigh the terrifying risk of causing an intracerebral hemorrhage against the risk of an ischemic stroke, guiding the use of novel oral anticoagulants (NOACs) in this high-risk population.
Frequently Asked Questions (FAQs)
Does this book address cognitive impairment?
Yes, it rigorously explores the strong correlation between a high microbleed burden and the development of vascular dementia and executive dysfunction.
Who is the primary audience?
It is the absolute, mandatory clinical guide for Stroke Neurologists, Neuroradiologists, Geriatricians, and Cardiovascular Specialists managing anticoagulation.
